Companies · Biotech / Pharma

Capri Bio Cafe

South Africa · Biotech / Pharma

Diligence memoA one-page analyst read on Capri Bio Cafe — recommendation, valuation, rhythm, risks.
Total raised · real
0
Rounds
Latest step-up
Top 96%
Sector rank · raised
Latest stage · inferred

Capri Bio Cafe: limited disclosed financing to assess.

Synthesized from the figures below est. — every claim rests on a number shown on this page.

Where it sits in Biotech / Pharma

Capri Bio Cafe is one of 227 Biotech / Pharma companies tracked from South Africa. By capital raised it ranks in the long tail (ahead of 5% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

South African company.

As reported in public records reported — not modeled.

ZA
Jurisdiction
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

No round amounts on record to chart.

Financing ladder & sequence gaps

No staged rounds to sequence.

Modeled valuation trajectory
Base estimate est.
Conservative case
Upside case
Modeled post-money

Round size and date are reported; the stage label is inferred from round size. Valuation is modeled from stage benchmarks. Directional, not a quoted figure.

Not enough modeled valuation points to chart a trajectory.

Financing rhythm
Avg between rounds
Capital velocity
On record since
First round
0
Rounds on file
How it compares to the market

Benchmarked against 227 companies in Biotech / Pharma. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages)
This company
Sector median$5.6M
Modeled value — vs sector median (estimate, all stages)
This company
Sector median$30.5M

Raised more than 5% of sector peers (real $). Modeled value above 5% of peers (estimate).

Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
No rounds recorded.
Intelligence
Modeled next raise
Modeled next size est.
Last step-up
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
3Bar Biologics, Inc.Biotech / PharmaSeed$2.4M$26.1Msame sector
3F Bio LtdBiotech / PharmaSeries A$7.2M$45.2Msame sector
64x BioBiotech / Pharmasame sector
A-Alpha Bio, Inc.Biotech / PharmaSeries B$23.1M$464.7Msame sector
Abreos Biosciences, Inc.Biotech / PharmaSeries A$7.5M$172.5Msame sector
Abrexa Pharmaceuticals, Inc.Biotech / PharmaSeries B$40.1M$118.0Msame sector
AbX Biologics, Inc.Biotech / PharmaPre-Seed$1.0M$51.2Msame sector
Accipiter Biosciences Inc.Biotech / PharmaSeries A$14.2M$74.9Msame sector
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Oxford Bio Cafe
South African company.
Biotech / Pharma87%
Bio
South African company.
Biotech / Pharma83%
Roxy Bio Cafe
South African company.
Biotech / Pharma83%
National Bioproducts Institute (South Africa)
South African company, based in Durban.
79%
The Africa Cafe
South African company.
Food & Beverage78%
Truth Coffee
South African company.
Agtech / Foodtech77%
Vida e Caffè
South African company.
77%
CapeBio
South African company, based in Pretoria. Sector: biotechnology.
biotechnology77%
Frequently asked
What does Capri Bio Cafe do and where is it based?
Capri Bio Cafe operates in the Biotech / Pharma sector, based in South Africa. South African company.
Explore related

See where Capri Bio Cafe sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Capri Bio Cafe, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.